CIK 0001625101 · Non-accelerated filer<br>Smaller reporting company
PULSE BIOSCIENCES, INC.
Sign in to watch- Ticker
- PLSE
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 465696597
- Phone
- 510-906-4600
- Business address
- 3957 POINT EDEN WAY, HAYWARD, CA, 94545
- Former names
- Electroblate, Inc.
- Open-market buys, last 90 days
- $199,937
- in 2 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$199,937. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-06-06 | Zanganeh Mahkam Director | Grant or award · Stock Option (right to buy) | +20,000 | 20,000 | ||
| 2024-06-06 | Zanganeh Mahkam Director | Grant or award · Stock Option (right to buy) | +8,247 | 8,247 | ||
| 2024-06-06 | van den Broek Richard Director | Grant or award · Stock Option (right to buy) | +20,000 | 20,000 | ||
| 2024-06-06 | van den Broek Richard Director | Grant or award · Stock Option (right to buy) | +11,649 | 11,649 | ||
| 2024-06-06 | Soni Manmeet Singh Director | Grant or award · Stock Option (right to buy) | +20,000 | 20,000 | ||
| 2024-06-06 | DUGGAN ROBERT W Director | Grant or award · Stock Option (right to buy) | +20,000 | 20,000 | ||
| 2024-06-06 | DUGGAN ROBERT W Director | Grant or award · Stock Option (right to buy) | +16,247 | 16,247 | ||
| 2024-05-20 | Barrett Burke Thomas President and CEO | Purchase | +10,000 | $8.56 | $86K | 10,000 |
| 2024-05-12 | Barrett Burke Thomas President and CEO | Grant or award · Stock Option (right to buy) | +700,000 | 700,000 | ||
| 2024-05-12 | Barrett Burke Thomas President and CEO | Grant or award · Stock Option (right to buy) | +700,000 | 700,000 | ||
| 2023-12-12 | DUGGAN ROBERT W Director | Purchase | +17,999 | $9.15 | $165K | 36,984,179 |
| 2023-12-11 | DUGGAN ROBERT W Director | Purchase | +90,118 | $9.36 | $844K | 36,966,180 |
| 2023-12-08 | DUGGAN ROBERT W Director | Purchase | +116,656 | $9.54 | $1.1M | 36,876,062 |
| 2023-12-07 | DUGGAN ROBERT W Director | Purchase | +74,852 | $9.19 | $688K | 36,759,406 |
| 2023-12-06 | DUGGAN ROBERT W Director | Option exercise | +9,933 | $5.95 | $59K | 36,601,741 |
| 2023-12-06 | DUGGAN ROBERT W Director | Purchase | +82,813 | $9.06 | $750K | 36,684,554 |
| 2023-12-06 | DUGGAN ROBERT W Director | Option exercise · Stock Option (right to buy) | −9,933 | 0 | ||
| 2023-12-05 | DUGGAN ROBERT W Director | Purchase | +66,021 | $9.34 | $617K | 351,565 |
| 2023-12-04 | DUGGAN ROBERT W Director | Option exercise | +20,000 | $10.66 | $213K | 36,571,461 |
| 2023-12-04 | DUGGAN ROBERT W Director | Option exercise | +20,347 | $10.66 | $217K | 36,591,808 |
Page 9 of 15 · 292 trades